Aurobindo Pharma reported INR585.02B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Cipla INR 424.96B 23.32B Mar/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Dr.Reddys Laboratories INR 581.23B 18.34B Mar/2026
Hindustan Unilever INR 797.52B 22.82B Mar/2026
Sun Pharmaceuticals INR 1.09T 50.79B Mar/2026
UPL INR 952.05B 38.14B Mar/2026